Wegovy, Ozempic maker to face off on Capitol Hill over high prices
In a new push to make popular weight loss drugs more affordable, the CEO of Novo Nordisk is set to face a grilling on Capitol Hill over the high cost of Ozempic, used to treat type 2 diabetes, and Wegovy which is approved for weight loss. NBC’s Christine Romans reports for TODAY.
Expert Calls for Research into GLP-1s for Mental Illness
Recent research easing suicidality concerns about GLP-1s and suggesting potential psychiatric benefit has led to a call for further study of these drugs for mental illness. Medscape Medical News
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify on Capitol Hill Tuesday.
Experts Fear GLP-1 Drugs Could Trigger Teen Eating Disorders
Physicians fear use of weight loss drugs in teens will increase or exacerbate eating disorder cases, adding complexity to treatment. Medscape Medical News
GLP-1 Use and Costs Among US Adults With Type 2 Diabetes
This JAMA Data Brief discusses new data from the Medical Expenditure Panel Survey, or MEPS, Household Component, a household survey sponsored by the Agency for Healthcare Research and Quality.
Novo Says Ozempic to Be Eligible for US Price Negotiations in Less Than a Year
Novo Nordisk’s blockbuster diabetes drug Ozempic will be eligible for U.S. government’s price negotiations in less than a year based on current criteria, the Danish… Reuters Health Information
Federal Housing Assistance is Associated With Earlier-Stage Breast, Colorectal and Lung Cancer Diagnosis, New Study Finds
The American Cancer Society led research to be presented at the 2024 ASCO Quality Care Symposium
Megyn Kelly: I Miss ‘Fat’ and ‘Genuine’ Pre-Ozempic Oprah
Reuters and Getty ImagesMegyn Kelly says she misses the “fat” Oprah Winfrey of old, claiming the iconic TV host has lost her heart, “along with the pounds,” as she’s recently opted to take a weight loss drug.Kelly, the 53-year-old former Fox News anchor, told podcast listeners Friday that she finds Winfrey, 70, less trustworthy since she began taking a weight loss medication. “I miss fat Oprah, she was just genuine,” Kelly said on the The Megyn Kelly Show. “Now this thin Ozempic Oprah has lost—along with the pounds, her heart—her sense of authenticity.”Read more at The Daily Beast.
Datopotamab deruxtecan may be a novel improvement for inoperable breast cancer
1. Compared to chemotherapy, patients with inoperable hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer receiving the antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) experienced significant improvements in progression-free survival (PFS) with a favourable and manageable safety profile. Evidence Rating Level: 1 (Excellent) Study Rundown: In recent years, the standard of care for patients
The post Datopotamab deruxtecan may be a novel improvement for inoperable breast cancer first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
Does Bariatric Surgery Also Improve Thyroid Function?
Metabolic/bariatric surgery improved thyroid function and hormone resistance in patients with obesity, which was correlated with improvement in body composition. Medscape Medical News